Since the start of theCOVID-19pandemic, cancer screenings for breast and colon cancer, have dropped significantly.
A study published in theJournal of the American Medical Associationshows “an estimated screening deficit of 9.4 million.”
“COVID put cancer and health-care disparities on steroids,” Oncologist Kashyap Patel said toThe Washington Post.
“I have never seen this many people presenting at Stage 3 and 4.”
Americans have been able to take care of themselves a little easier thanks to the focus on telehealth.
The pandemic already helped promote thefecal immunochemical test(FIT), a home-based screening for colorectal cancer.
